Arie Belldegrun raises $300M, grabs Pfizer’s allogeneic CAR-T portfolio and launches a groundbreaking drive to commercialization admin April 4, 2018 PR You Might Also Like Israeli startup seeks to boost bone renewal and allow targeted drug delivery May 16, 2019 If pharma looks slow to adopt AI, it’s got good reason, expert says May 2, 2019 Mining data, Israeli healthcare provider flags colon-cancer risk patients April 16, 2019
